Tissue Regeneration gets FDA OK for 3D-printed cranial reconstruction device

09/3/2013 | MassDevice.com (Boston)

The FDA has cleared Tissue Regeneration Systems to market its Cranial Bone Void Filler, a 3D-printed cranial reconstruction device used to close holes in the skulls of patients who have undergone surgery. "To our knowledge, this is the first FDA approval of a coated bioresorbable skeletal reconstruction implant fabricated by means of 3D printing," said Jim Fitzsimmons, the company's president and CEO.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC